Wellbiotec Co., Ltd. (KRX:010600)

Wellbiotec Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,182	49,553	109,562	70,750	103,564	105,484
Market Cap Growth	-97.33%	-54.77%	54.86%	-31.69%	-1.82%	12.25%
Enterprise Value	-2,863	42,228	85,070	58,380	137,859	134,707
Last Close Price	24.00	545.00	1205.00	1065.00	1765.00	2340.00
PS Ratio	0.03	0.60	1.83	0.45	0.96	1.75
PB Ratio	0.14	2.46	2.94	2.00	2.80	5.41
P/TBV Ratio	0.15	2.48	2.90	2.31	3.28	8.66
P/FCF Ratio	-	-	-	47.86	-	-
P/OCF Ratio	-	-	-	35.73	193.35	-
EV/Sales Ratio	-	0.51	1.42	0.37	1.27	2.23
EV/EBITDA Ratio	-	-	-	22.06	-	-
EV/EBIT Ratio	-	-	-	45.40	-	-
EV/FCF Ratio	1.15	-	-	39.49	-	-
Debt / Equity Ratio	0.08	0.09	0.22	0.18	0.65	2.11
Debt / EBITDA Ratio	-	-	-	2.34	-	-
Debt / FCF Ratio	-	-	-	4.20	-	-
Asset Turnover	2.47	1.81	1.00	1.59	1.03	0.63
Inventory Turnover	-	-	38.30	95.32	27.59	4.77
Quick Ratio	1.59	1.72	1.58	1.73	0.35	0.53
Current Ratio	2.06	2.24	1.88	2.06	0.48	0.71
Return on Equity (ROE)	-60.45%	-66.96%	-166.97%	-58.13%	-123.42%	-107.03%
Return on Assets (ROA)	-8.61%	-7.94%	-15.63%	0.81%	-2.56%	-8.30%
Return on Capital (ROIC)	-11.85%	-10.85%	-21.48%	1.57%	-4.43%	-10.07%
Return on Capital Employed (ROCE)	-27.60%	-27.60%	-37.70%	3.50%	-10.20%	-43.40%
Earnings Yield	-698.97%	-42.82%	-59.25%	-29.51%	-32.13%	-63.92%
FCF Yield	-113.94%	-12.45%	-4.79%	2.09%	-0.03%	-6.40%
Buyback Yield / Dilution	13.41%	-0.00%	-23.12%	-16.20%	-26.70%	-5.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.